Loading organizations...
Key people at Syneron Candela.
Syneron Candela was founded in 1970 by Shimon Eckhouse (Co founder and chairman of the board).
Candela Medical develops and manufactures medical aesthetic devices, delivering solutions for treatments ranging from laser hair removal and skin rejuvenation to pigmented lesion removal and tattoo clearance. The company integrates various energy-based technologies like lasers, IPL, hydrodermabrasion, and radiofrequency microneedling, providing precise tools.
The company’s foundation traces to Candela Corporation, established in 1970 by physicist Horace Furumoto for medical applications. Separately, Syneron Medical, co-founded in 2000 by Shimon Eckhouse, Dr. Aharon Aharon, and Dr. Keren Shatz, pioneered aesthetic devices with elōs technology. Syneron acquired Candela in 2009, merging their expertise into the entity that eventually became Candela Medical.
Candela Medical’s clientele comprises medical aesthetic practitioners, dermatologists, and medical spas seeking advanced equipment. The company provides versatile tools addressing diverse patient concerns, enhancing clinical offerings and outcomes. Candela’s vision focuses on advancing medical aesthetics through innovation, delivering reliable, science-based energy devices that expand treatment possibilities and establish new standards in patient care.
Syneron Candela was founded in 1970 by Shimon Eckhouse (Co founder and chairman of the board).
Syneron Candela is a leading global medical aesthetic device company specializing in laser, IPL, and RF microneedling technologies for dermatology and esthetics. It develops and manufactures devices like the GentleMax Pro for hair removal, Vbeam for vascular treatments, and PicoWay for pigmentation and tattoos, serving plastic surgeons, dermatologists, hospitals, and medical spas in over 90 countries.[1][2][4] The company solves problems in non-invasive aesthetic treatments—such as hair removal, skin rejuvenation, vascular lesions, and tattoo removal—by combining innovative energy-based technologies for safer, more effective results with features like dynamic cooling and electro-optical synergy (elōs).[1][3][4] Post-merger growth has been strong, marked by product launches (e.g., Vbeam Prima, CO2RE Intima), acquisitions (e.g., Ellipse A/S), and a 2019 rebrand to Candela Medical, solidifying its market leadership.[2][4]
Syneron was founded in 2000 in Israel by Shimon Eckhouse, Dr. Aharon Aharon, and Dr. Keren Shatz, driven by Dr. Michael Kreindel's research into elōs technology, which overcame limitations of traditional lasers and intense pulsed light for aesthetics like wrinkle reduction and hair removal.[1][3] It quickly launched five product families, establishing itself as an innovator in radiofrequency and laser devices.[3]
Candela Corporation, tracing back to 1970 in Boston (with roots in 1971 via founder Nick Furumoto's pulsed dye laser work), pioneered the aesthetic laser market, inventing the first vascular lesion laser for children, Q-switched alexandrite for tattoos, and dynamic cooling device (DCD).[2][3][4] The companies merged in 2008 (announced 2009), combining Syneron's innovation with Candela's legacy to form Syneron-Candela, later rebranded Candela Medical in 2019 with a new HQ in Marlborough, MA.[1][2][4][5] This union expanded portfolios and market reach amid industry consolidation post-2008 economic downturn.[3]
Syneron Candela rides the surge in non-invasive aesthetics, fueled by rising demand for minimally invasive beauty treatments amid aging populations and social media-driven wellness trends.[1][3] Its timing leverages 1970s laser foundations evolving into today's picosecond and hybrid RF systems, capitalizing on post-2008 M&A waves for scale.[3][4] Market forces like medspa growth and physician adoption favor it, as devices become "gold standards" for vascular, pigmentation, and rejuvenation issues previously hard to treat safely.[2] The company influences the ecosystem by setting innovation benchmarks—e.g., first child-safe vascular lasers—and enabling practitioners worldwide via accessible, high-ROI tech.[1][2][4]
Syneron Candela's trajectory points to continued dominance through RF microneedling expansions, picosecond advancements (e.g., new PicoWay handpieces), and acquisitions like Ellipse for IPL versatility.[4] Trends like AI-integrated devices, personalized aesthetics, and feminine health will shape it, with APAX Partners' 2019 ownership providing capital for R&D amid global medtech growth.[4] Its influence may evolve from pioneer to platform leader, powering ecosystem-wide standards in energy-based treatments—echoing its merger-forged strength that transformed cosmetics from "fantastic" results to everyday reality.[2][3]
Key people at Syneron Candela.
